Rob C.M. van Kruijsdijk

1.0k total citations · 1 hit paper
12 papers, 766 citations indexed

About

Rob C.M. van Kruijsdijk is a scholar working on Cardiology and Cardiovascular Medicine, Oncology and Surgery. According to data from OpenAlex, Rob C.M. van Kruijsdijk has authored 12 papers receiving a total of 766 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Cardiology and Cardiovascular Medicine, 4 papers in Oncology and 3 papers in Surgery. Recurrent topics in Rob C.M. van Kruijsdijk's work include Health Systems, Economic Evaluations, Quality of Life (2 papers), Cancer Risks and Factors (2 papers) and Colorectal Cancer Treatments and Studies (2 papers). Rob C.M. van Kruijsdijk is often cited by papers focused on Health Systems, Economic Evaluations, Quality of Life (2 papers), Cancer Risks and Factors (2 papers) and Colorectal Cancer Treatments and Studies (2 papers). Rob C.M. van Kruijsdijk collaborates with scholars based in Netherlands, United States and United Kingdom. Rob C.M. van Kruijsdijk's co-authors include Frank L.J. Visseren, Elsken van der Wall, Yolanda van der Graaf, Petra H.M. Peeters, Paul M. Ridker, Nancy R. Cook, Joris van der Heijden, Jannick A N Dorresteijn, Luuk Otterspoor and Lotte Kaasenbrood and has published in prestigious journals such as BMJ, Annals of Oncology and Heart.

In The Last Decade

Rob C.M. van Kruijsdijk

11 papers receiving 751 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Obesity and Cancer: The Role of Dysfunctional Adipose Tissue

2009 559 citations Rob C.M. van Kruijsdijk, Elsken van der Wall et al. Cancer Epidemiology Biomarkers & Prevention profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Rob C.M. van Kruijsdijk Netherlands	7	277	213	183	183	167	12	766
Stavroula Tsiara Greece	15	221 0.8×	249 1.2×	95 0.5×	110 0.6×	98 0.6×	38	1.0k
Rhonda Arthur United States	19	378 1.4×	207 1.0×	114 0.6×	222 1.2×	232 1.4×	45	1.1k
Sheetal Hardikar United States	16	272 1.0×	136 0.6×	94 0.5×	110 0.6×	150 0.9×	46	782
Kyung Hee Yi South Korea	15	270 1.0×	206 1.0×	101 0.6×	90 0.5×	78 0.5×	28	1.0k
Y.-T. Gao China	11	278 1.0×	258 1.2×	107 0.6×	176 1.0×	113 0.7×	14	795
Chia‐Chang Hsu Taiwan	17	137 0.5×	163 0.8×	334 1.8×	58 0.3×	105 0.6×	50	921
Claire Siemes Netherlands	13	250 0.9×	138 0.6×	127 0.7×	135 0.7×	38 0.2×	21	869
Jan Stratmann Germany	13	240 0.9×	130 0.6×	100 0.5×	44 0.2×	86 0.5×	48	818
Michelle Jankowski United States	16	126 0.5×	195 0.9×	74 0.4×	128 0.7×	81 0.5×	35	832
S. M. Gapstur United States	10	513 1.9×	307 1.4×	108 0.6×	145 0.8×	139 0.8×	11	1.0k

Countries citing papers authored by Rob C.M. van Kruijsdijk

Since Specialization

Citations

This map shows the geographic impact of Rob C.M. van Kruijsdijk's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rob C.M. van Kruijsdijk with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rob C.M. van Kruijsdijk more than expected).

Fields of papers citing papers by Rob C.M. van Kruijsdijk

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rob C.M. van Kruijsdijk. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rob C.M. van Kruijsdijk. The network helps show where Rob C.M. van Kruijsdijk may publish in the future.

Co-authorship network of co-authors of Rob C.M. van Kruijsdijk

This figure shows the co-authorship network connecting the top 25 collaborators of Rob C.M. van Kruijsdijk. A scholar is included among the top collaborators of Rob C.M. van Kruijsdijk based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rob C.M. van Kruijsdijk. Rob C.M. van Kruijsdijk is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

12 of 12 papers shown

Kruijsdijk, Rob C.M. van, Valentina Angerilli, Marije C. Baas, et al.. (2025). Risk of deficient mismatch repair colorectal cancer and precursors after kidney transplantation: A nationwide study. American Journal of Transplantation. 26(3). 480–488.

Sprangers, Ben, Alferso C Abrahams, Priyanka Koshy, et al.. (2024). Proliferative glomerulonephritis with monoclonal immunoglobulin deposits in the native or posttransplant kidney. Nephrology Dialysis Transplantation. 39(5). 888–892. 2 indexed citations

Kruijsdijk, Rob C.M. van, Robin W.M. Vernooij, Sanne A. E. Peters, et al.. (2022). Personalizing treatment in end-stage kidney disease: deciding between haemodiafiltration and haemodialysis based on individualized treatment effect prediction. Clinical Kidney Journal. 15(10). 1924–1931. 6 indexed citations

Kruijsdijk, Rob C.M. van, Alferso C Abrahams, Tri Q. Nguyen, et al.. (2020). Clone-directed therapy for proliferative glomerulonephritis with monoclonal immunoglobulin depositions: is it always necessary?. Journal of Nephrology. 33(3). 611–617. 8 indexed citations

Kwakman, Johannes J.M., Rob C.M. van Kruijsdijk, Sjoerd G. Elias, et al.. (2019). Choosing the right strategy based on individualized treatment effect predictions: combination versus sequential chemotherapy in patients with metastatic colorectal cancer. Acta Oncologica. 58(3). 326–333. 2 indexed citations

Kruijsdijk, Rob C.M. van, Frank L.J. Visseren, Luca Boni, et al.. (2016). Pemetrexed plus carboplatin versus pemetrexed in pretreated patients with advanced non-squamous non-small-cell lung cancer: treating the right patients based on individualized treatment effect prediction. Annals of Oncology. 27(7). 1280–1286. 4 indexed citations

Dorresteijn, Jannick A N, Lotte Kaasenbrood, Nancy R. Cook, et al.. (2016). How to translate clinical trial results into gain in healthy life expectancy for individual patients. BMJ. 352. i1548–i1548. 45 indexed citations

Kruijsdijk, Rob C.M. van, et al.. (2014). The relation between resting heart rate and cancer incidence, cancer mortality and all-cause mortality in patients with manifest vascular disease. Cancer Epidemiology. 38(6). 715–721. 15 indexed citations

Kruijsdijk, Rob C.M. van, Frank L.J. Visseren, Paul M. Ridker, et al.. (2014). Individualised prediction of alternate-day aspirin treatment effects on the combined risk of cancer, cardiovascular disease and gastrointestinal bleeding in healthy women. Heart. 101(5). 369–376. 36 indexed citations

10.

Kruijsdijk, Rob C.M. van, et al.. (2013). Cancer Risk in Patients with Manifest Vascular Disease: Effects of Smoking, Obesity, and Metabolic Syndrome. Cancer Epidemiology Biomarkers & Prevention. 22(7). 1267–1277. 60 indexed citations

11.

Kruijsdijk, Rob C.M. van, et al.. (2011). Sepsis-Related Myocardial Calcification. Circulation Heart Failure. 4(5). e16–8. 29 indexed citations

12.

Kruijsdijk, Rob C.M. van, Elsken van der Wall, & Frank L.J. Visseren. (2009). Obesity and Cancer: The Role of Dysfunctional Adipose Tissue. Cancer Epidemiology Biomarkers & Prevention. 18(10). 2569–2578. 559 indexed citations breakdown →

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact